The Primary
Care Companionfor CNS Disorders

Anxiety

Article October 1, 2001

Introduction: Remission of Anxiety-Related Disorders

Richard C. Shelton

J Clin Psychiatry 2001;62(suppl 12):3-4

Article Abstract

Introduction: Remission of Anxiety-Related Disorders.

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 27 • 2025 • Number 1

Read the Current Issue

Rounds in the General Hospital

Psychosis-Related PTSD

Case Report

Thyrotoxic Psychosis in Graves’ Disease

Case Report

Factitious Disorder in the Context of Abuse in an Adolescent

Rounds in the General Hospital

Wishing That Your Patient Would Die: Reasons and Reactions

Case Report

Frontal Lobe Syndrome Unveils an Unexpected Diagnosis

Case Report

Low-Dose Clozapine in Schizophrenia With Aggression

View current Issue

Article

Anxiety Disorders in Older Patients

January 31, 2019

Anxiety complaints are common among older adults, especially those with chronic illnesses. This narrative review describes the characteristics of common anxiety disorders among older people and provides treatment guidelines.

Raymond Pary , Simrat Kaur Sarai , Anthony Micchelli , et al

Article

Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis

January 29, 2019

When you treat youth with anxiety disorders, are your decisions evidence-based? This meta-analysis examined efficacy and tolerability of agents studied for pediatric anxiety in double-blind, placebo-controlled trials. Read the...

Eric T. Dobson , Michael H. Bloch , Jeffrey R. Strawn

Article

Mindfulness-Based Stress Reduction for Older Adults

August 23, 2017

Stress and stress-related disorders such as depression and anxiety can accelerate neurocognitive aging. Could a mindfulness intervention be a way to enhance memory and clinical outcomes in older patients?...

Julie Loebach Wetherell , Tamara Hershey , Steven Hickman , et al

Introduction: Remission of Anxiety-Related Disorders

Read the Current Issue

Psychosis-Related PTSD

Thyrotoxic Psychosis in Graves’ Disease

Factitious Disorder in the Context of Abuse in an Adolescent

Wishing That Your Patient Would Die: Reasons and Reactions

Frontal Lobe Syndrome Unveils an Unexpected Diagnosis

Low-Dose Clozapine in Schizophrenia With Aggression

ELSEWHERE:

FOLLOW US:

Introduction: Remission of Anxiety-Related Disorders

Read the Current Issue

Psychosis-Related PTSD

Thyrotoxic Psychosis in Graves’ Disease

Factitious Disorder in the Context of Abuse in an Adolescent

Wishing That Your Patient Would Die: Reasons and Reactions

Frontal Lobe Syndrome Unveils an Unexpected Diagnosis

Low-Dose Clozapine in Schizophrenia With Aggression

Related Articles

Anxiety Disorders in Older Patients

Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis

Mindfulness-Based Stress Reduction for Older Adults

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles